JAM
NVS icon

Jolley Asset Management’s Novartis NVS Stock Holding History

Jolley Asset Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$3.87M Sell
46,955
-742
-2% -$66.2K 2.98% 9
2019
Q4 		$4.52M Sell
47,697
-3,135
-6% -$281K 2.57% 20
2019
Q3 		$4.42M Sell
50,832
-21
-0% -$1.89K 2.87% 22
2019
Q2 		$4.64M Sell
50,853
-5,547
-10% -$469K 2.98% 18
2019
Q1 		$4.86M Buy
56,400
+459
+0.8% +$36.8K 3.52% 5
2018
Q4 		$4.3M Buy
55,941
+413
+0.7% +$32.1K 3.3% 10
2018
Q3 		$4.29M Buy
55,528
+480
+0.9% +$35.5K 2.88% 14
2018
Q2 		$3.73M Buy
55,048
+659
+1% +$45.5K 2.49% 22
2018
Q1 		$3.94M Buy
54,389
+1,467
+3% +$112K 2.39% 23
2017
Q4 		$3.98M Buy
52,922
+530
+1% +$40K 2.53% 20
2017
Q3 		$4.03M Sell
52,392
-583
-1% -$44K 2.73% 16
2017
Q2 		$3.96M Buy
52,975
+50
+0.1% +$3.54K 2.78% 15
2017
Q1 		$3.52M Buy
52,925
+2,143
+4% +$143K 2.53% 24
2016
Q4 		$3.31M Buy
50,782
+4,825
+10% +$313K 2.38% 25
2016
Q3 		$3.25M Buy
45,957
+599
+1% +$43.6K 2.63% 23
2016
Q2 		$3.35M Sell
45,358
-2,775
-6% -$192K 2.7% 19
2016
Q1 		$3.12M Buy
48,133
+7,303
+18% +$497K 2.84% 17
2015
Q4 		$3.15M Buy
40,830
+586
+1% +$46.6K 2.99% 14
2015
Q3 		$3.31M Sell
40,244
-318
-0.8% -$28.3K 3.36% 9
2015
Q2 		$3.57M Sell
40,562
-722
-2% -$66.2K 3.25% 12
2015
Q1 		$3.65M Sell
41,284
-2,059
-5% -$183K 3.03% 12
2014
Q4 		$3.6M Buy
43,343
+102
+0.2% +$8.46K 2.98% 17
2014
Q3 		$3.65M Sell
43,241
-1,103
-2% -$89.2K 2.94% 12
2014
Q2 		$3.6M Sell
44,344
-2,712
-6% -$213K 2.64% 19
2014
Q1 		$3.58M Sell
47,056
-857
-2% -$62.4K 2.67% 23
2013
Q4 		$3.45M Sell
47,913
-624
-1% -$43.4K 2.72% 20
2013
Q3 		$3.34M Sell
48,537
-2,014
-4% -$133K 2.78% 16
2013
Q2 		$3.2M Buy
+50,551
New +$3.29M 2.59% 23

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jolley Asset Management's NVS Position: Q1 2020 in Review

Jolley Asset Management reduced its Novartis (NVS) stake by 1.6% in Q1 2020, selling an estimated $66.2K and leaving 46,955 shares worth $3.87M. The position accounts for 2.98% of the portfolio, ranked #9.

Jolley Asset Management first reported a position in NVS in Q2 2013 and has held it in 28 quarters since. The position peaked at $4.86M in Q1 2019. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • Jolley Asset Management held 46,955 shares of Novartis worth $3.87M as of Q1 2020.
  • Jolley Asset Management sold 742 Novartis shares in Q1 2020, an estimated $66.2K.
  • Novartis made up 2.98% of Jolley Asset Management's portfolio in Q1 2020, its #9 holding.
  • Jolley Asset Management first reported a position in Novartis in Q2 2013 and has held it in 28 quarters since.
  • Jolley Asset Management's Novartis position peaked at $4.86M in Q1 2019.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Jolley Asset Management's 13F filing for Q1 2020, filed 15 Apr 2020.